©2024 Stanford Medicine
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
Not Recruiting
Trial ID: NCT00091091
Purpose
RATIONALE: Assessing the long-term effects of cancer treatment in cancer survivors may help
improve the ability to plan effective treatment and follow-up care.
PURPOSE: This clinical trial is studying the long-term effects of treatment in patients who
were previously treated for childhood Hodgkin's lymphoma.
Official Title
Health-Related Outcomes For Hodgkin's Disease Survivors
Stanford Investigator(s)
Eligibility
DISEASE CHARACTERISTICS:
- Contemporary cohort
- At least 5 years since diagnosis of Hodgkin's lymphoma
- Diagnosed between the years 1987-2001
- 21 and under at diagnosis
- No evidence of disease
- Prior treatment on 1 of the following protocols during the years 1987-2001:
- Children's Cancer Group (CCG) CCG-5942, CCG-59704
- Pediatric Oncology Group (POG) POG-8625, POG-8725, POG-9425, POG-9426
- Pediatric Hodgkin's Consortium: VAMP, VEPA, VAMP/COP
- Institutional protocols COPP/ABV, MOPP/ABVD, ABVD
- Childhood Cancer Survivor Study (CCSS) Hodgkin's lymphoma cohort
- Current enrollment in the CCSS
- Diagnosed between the years 1976-1986
- Completed baseline questionnaire at comparable timepoints (as the contemporary
cohort) after diagnosis
PATIENT CHARACTERISTICS:
Age
- Any age
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Intervention(s):
other: medical chart review
other: questionnaire administration
procedure: management of therapy complications
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jennifer Lew
6507254318